Ipca Laboratories consolidated net profit rises 72.33% in the June 2026 quarter

Sales rise 20.76% to Rs 2788.10 crore

Net profit of Ipca Laboratories rose 72.33% to Rs 401.89 crore in the quarter ended June 2026 as against Rs 233.21 crore during the previous quarter ended June 2025. Sales rose 20.76% to Rs 2788.10 crore in the quarter ended June 2026 as against Rs 2308.85 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	2788.10	2308.85	21
OPM %	24.01	18.04	-
PBDT	682.89	430.57	59
PBT	572.08	330.51	73
NP	401.89	233.21	72

Powered by Capital Market - Live News